Real Medical Services Expenditures by Disease: Diseases of the Circulatory System, Blended Account Basis (DICISYREXBLEND) | FRED | St. Louis Fed
- Rows
- 22
- Columns
- 2
- Data range
- 2000-01-01 to 2021-01-01
Graph and download economic data for Real Medical Services Expenditures by Disease: Diseases of the Circulatory System, Blended Account Basis (DICISYREXBLEND) from 2000 to 2021 about disease, healthcare, medical, health, expenditures, services, real, and USA.
AI analysis
Dataset Analysis: Real Medical Services Expenditures — Diseases of the Circulatory System
1. Dataset Overview and Context
This dataset, sourced from the St. Louis Fed's FRED database (via fredgraph.csv?id=DICISYREXBLEND), tracks real (inflation-adjusted) medical services expenditures specifically attributable to circulatory system diseases (e.g., heart disease, hypertension, stroke) in the USA, using a "blended account basis" methodology. The FRED source lends strong credibility and freshness assurance—FRED is a well-maintained, authoritative aggregator that pulls from federal statistical agencies (likely CMS/BEA health expenditure accounts) and updates on a predictable schedule. With annual observations spanning 2000 to 2021 (22 data points), this series is valuable for long-run trend analysis and as a macro-level health-cost benchmark. Its primary value for correlation studies lies in pairing it with other annual, disease-specific or economy-wide time series to explore how cardiovascular care spending relates to demographic, policy, or risk-factor trends.
2. Data Quality Observations
Data quality appears excellent at face value: zero null cells across both columns and 22 distinct values in each column (matching the 22 total rows), indicating no missing observations and no duplicate timestamps. There is no disproportionate null concentration in either the date key or the value column. However, one caveat worth flagging: the "Duplicate rows" metric is listed as pending recomputation ("Phase D — recomputed against Parquet"), so full duplicate-integrity confirmation is not yet available. Additionally, sample rows are not yet populated, meaning visual/spot-checking of actual values against metadata stats hasn't been done—this should be validated before downstream use.
3. Key Column Distributions
The core metric, DICISYREXBLEND, ranges from 226.4 to 265.6, with a mean of 246.5 and median of 247.97—the median exceeding the mean suggests a mild left skew, confirmed by the skewness statistic of -0.378 (a modest negative skew, indicating a slightly longer left tail, possibly reflecting lower expenditure values in earlier years like 2000-2005 before a plateau or acceleration). The interquartile range (Q1=240.1, Q3=253.4) is relatively narrow (~13.3 units) compared to the full range (~39.2), suggesting most observations cluster centrally with a few lower outlier years pulling the distribution down. The standard deviation of 10.9 relative to the mean indicates moderate but not extreme year-over-year variability (~4.4% coefficient of variation)—consistent with a slow-moving, policy-and-demographics-driven cost series rather than a volatile financial metric.
4. Recommended Join Key
The clear join key is observationdate, formatted as a standard ISO date (YYYY-01-01), representing annual periodicity. Since all values are anchored to January 1st of each year, this dataset should be joined on the year component with other annual datasets, or resampled/interpolated if joining against monthly or quarterly series (common in FRED health, CPI, or labor datasets).
5. Recommended Pairings for Correlation Analysis
Strong candidates for correlation studies include: (1) other FRED disease-expenditure series (e.g., cancer, respiratory, diabetes expenditures) to compare relative growth rates across disease categories; (2) Medical Care CPI or Producer Price Index for medical services, to distinguish whether spending growth is driven by price inflation versus utilization; (3) demographic data such as aging population percentages or obesity/hypertension prevalence rates (CDC/NHANES) to test whether risk-factor prevalence predicts expenditure; (4) GDP or personal health expenditure as % of GDP for macro-context normalization; and (5) insurance coverage rates or ACA implementation timelines (post-2010) to assess policy impact on circulatory disease spending trends.
Columns
- observation_date (date)
- DICISYREXBLEND (decimal)